| Horizon Homecare Llc | |
| 2977 Landover Blvd, Spring Hill, Florida 34608 | |
| (352) 684-3550 | |
| Name | Horizon Homecare Llc |
|---|---|
| Location | 2977 Landover Blvd, Spring Hill, Florida |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 108223 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 32159, 32162, 32163, 32668, 32686, 32696, 32726, 32735, 33513, 33521, 33538, 33585, 33597, 34420, 34423, 34428, 34429, 34431, 34432, 34433, 34434, 34436, 34442, 34446, 34448, 34449, 34450, 34451, 34452, 34453, 34461, 34465, 34470, 34471, 34472, 34473, 34474, 34475, 34476, 34479, 34480, 34481, 34482, 34488, 34491, 34498, 34601, 34602, 34604, 34606, 34607, 34608, 34609, 34613, 34614, 34661, 34731, 34748, 34785, 34788 |
| NPI Number | 1942255716 |
| Organization Name | HORIZON HOME CARE LLC |
| Doing Business As | CONCIERGE HOME CARE |
| Address | 2977 Landover Blvd, Spring Hill, FL 34608 |
| Phone Number | 352-684-3550 |
News Archive
A high concentration of indolepropionic acid in the serum protects against type 2 diabetes, shows a new study from the University of Eastern Finland. Indolepropionic acid is a metabolite produced by intestinal bacteria, and its production is boosted by a fibre-rich diet.
The Knut and Alice Wallenberg Foundation will give a little over SEK 16 million to the development of new, highly-efficient mucosal vaccines. The vaccines will be drinkable or given as a nasal spray. Professor Nils Lycke at MIVAC at the Sahlgrenska Academy will in cooperation with researchers at Chalmers University of Technology and Lund University, combine technologies to develop the next generation of effective mucosal vaccines based on immunomodulation and cell-targeted nanoparticles.
Argos Therapeutics Inc., an immuno-oncology company focused on the development and commercialization of fully individualized immunotherapies for the treatment of cancer based on the Arcelis technology platform, today announced the initiation of a single-center pilot clinical trial of AGS-003 as a neoadjuvant immunotherapy in patients with localized renal cell carcinoma.
President Barack Obama was slated to meet Tuesday with executives from leading technology companies, including Google, Microsoft and Apple, to solicit suggestions on the federal health care exchange website. The impact of federal surveillance efforts on those companies is also expected to come up.
› Verified 6 days ago
| Quality Rating: |
News Archive
A high concentration of indolepropionic acid in the serum protects against type 2 diabetes, shows a new study from the University of Eastern Finland. Indolepropionic acid is a metabolite produced by intestinal bacteria, and its production is boosted by a fibre-rich diet.
The Knut and Alice Wallenberg Foundation will give a little over SEK 16 million to the development of new, highly-efficient mucosal vaccines. The vaccines will be drinkable or given as a nasal spray. Professor Nils Lycke at MIVAC at the Sahlgrenska Academy will in cooperation with researchers at Chalmers University of Technology and Lund University, combine technologies to develop the next generation of effective mucosal vaccines based on immunomodulation and cell-targeted nanoparticles.
Argos Therapeutics Inc., an immuno-oncology company focused on the development and commercialization of fully individualized immunotherapies for the treatment of cancer based on the Arcelis technology platform, today announced the initiation of a single-center pilot clinical trial of AGS-003 as a neoadjuvant immunotherapy in patients with localized renal cell carcinoma.
President Barack Obama was slated to meet Tuesday with executives from leading technology companies, including Google, Microsoft and Apple, to solicit suggestions on the federal health care exchange website. The impact of federal surveillance efforts on those companies is also expected to come up.
› Verified 6 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 99.8 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 99.9 | 98.6 |
| How often the home health team checked patients’ risk of falling | 100 | 99.6 |
| How often the home health team checked patients for depression | 99.7 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 82.5 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 80.4 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 99.4 | 96.4 |
News Archive
A high concentration of indolepropionic acid in the serum protects against type 2 diabetes, shows a new study from the University of Eastern Finland. Indolepropionic acid is a metabolite produced by intestinal bacteria, and its production is boosted by a fibre-rich diet.
The Knut and Alice Wallenberg Foundation will give a little over SEK 16 million to the development of new, highly-efficient mucosal vaccines. The vaccines will be drinkable or given as a nasal spray. Professor Nils Lycke at MIVAC at the Sahlgrenska Academy will in cooperation with researchers at Chalmers University of Technology and Lund University, combine technologies to develop the next generation of effective mucosal vaccines based on immunomodulation and cell-targeted nanoparticles.
Argos Therapeutics Inc., an immuno-oncology company focused on the development and commercialization of fully individualized immunotherapies for the treatment of cancer based on the Arcelis technology platform, today announced the initiation of a single-center pilot clinical trial of AGS-003 as a neoadjuvant immunotherapy in patients with localized renal cell carcinoma.
President Barack Obama was slated to meet Tuesday with executives from leading technology companies, including Google, Microsoft and Apple, to solicit suggestions on the federal health care exchange website. The impact of federal surveillance efforts on those companies is also expected to come up.
› Verified 6 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 88 | 79.6 |
| How often patients got better at getting in and out of bed | 86.7 | 81.1 |
| How often patients got better at bathing | 94.6 | 82.3 |
| How often patients’ breathing improved | 90 | 82.8 |
| How often patients’ wounds improved or healed after an operation | 98.2 | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 95.2 | 75 |
| How often home health patients had to be admitted to the hospital | 16.7 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 8 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 99 | 94 |
News Archive
A high concentration of indolepropionic acid in the serum protects against type 2 diabetes, shows a new study from the University of Eastern Finland. Indolepropionic acid is a metabolite produced by intestinal bacteria, and its production is boosted by a fibre-rich diet.
The Knut and Alice Wallenberg Foundation will give a little over SEK 16 million to the development of new, highly-efficient mucosal vaccines. The vaccines will be drinkable or given as a nasal spray. Professor Nils Lycke at MIVAC at the Sahlgrenska Academy will in cooperation with researchers at Chalmers University of Technology and Lund University, combine technologies to develop the next generation of effective mucosal vaccines based on immunomodulation and cell-targeted nanoparticles.
Argos Therapeutics Inc., an immuno-oncology company focused on the development and commercialization of fully individualized immunotherapies for the treatment of cancer based on the Arcelis technology platform, today announced the initiation of a single-center pilot clinical trial of AGS-003 as a neoadjuvant immunotherapy in patients with localized renal cell carcinoma.
President Barack Obama was slated to meet Tuesday with executives from leading technology companies, including Google, Microsoft and Apple, to solicit suggestions on the federal health care exchange website. The impact of federal surveillance efforts on those companies is also expected to come up.
› Verified 6 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
A high concentration of indolepropionic acid in the serum protects against type 2 diabetes, shows a new study from the University of Eastern Finland. Indolepropionic acid is a metabolite produced by intestinal bacteria, and its production is boosted by a fibre-rich diet.
The Knut and Alice Wallenberg Foundation will give a little over SEK 16 million to the development of new, highly-efficient mucosal vaccines. The vaccines will be drinkable or given as a nasal spray. Professor Nils Lycke at MIVAC at the Sahlgrenska Academy will in cooperation with researchers at Chalmers University of Technology and Lund University, combine technologies to develop the next generation of effective mucosal vaccines based on immunomodulation and cell-targeted nanoparticles.
Argos Therapeutics Inc., an immuno-oncology company focused on the development and commercialization of fully individualized immunotherapies for the treatment of cancer based on the Arcelis technology platform, today announced the initiation of a single-center pilot clinical trial of AGS-003 as a neoadjuvant immunotherapy in patients with localized renal cell carcinoma.
President Barack Obama was slated to meet Tuesday with executives from leading technology companies, including Google, Microsoft and Apple, to solicit suggestions on the federal health care exchange website. The impact of federal surveillance efforts on those companies is also expected to come up.
› Verified 6 days ago
The patient survey data of Horizon Homecare Llc is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 86 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 84 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 84 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 81 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 74 | 78 |
News Archive
A high concentration of indolepropionic acid in the serum protects against type 2 diabetes, shows a new study from the University of Eastern Finland. Indolepropionic acid is a metabolite produced by intestinal bacteria, and its production is boosted by a fibre-rich diet.
The Knut and Alice Wallenberg Foundation will give a little over SEK 16 million to the development of new, highly-efficient mucosal vaccines. The vaccines will be drinkable or given as a nasal spray. Professor Nils Lycke at MIVAC at the Sahlgrenska Academy will in cooperation with researchers at Chalmers University of Technology and Lund University, combine technologies to develop the next generation of effective mucosal vaccines based on immunomodulation and cell-targeted nanoparticles.
Argos Therapeutics Inc., an immuno-oncology company focused on the development and commercialization of fully individualized immunotherapies for the treatment of cancer based on the Arcelis technology platform, today announced the initiation of a single-center pilot clinical trial of AGS-003 as a neoadjuvant immunotherapy in patients with localized renal cell carcinoma.
President Barack Obama was slated to meet Tuesday with executives from leading technology companies, including Google, Microsoft and Apple, to solicit suggestions on the federal health care exchange website. The impact of federal surveillance efforts on those companies is also expected to come up.
› Verified 6 days ago
Synergy Home Health Of Central Florida Location: 11026 Northcilffe Blvd Ste 1, Spring Hill, Florida 34608 Ratings: NA Phone: (352) 277-5934 | |
Comprehensive Home Care Of Hernando Llc Location: 5085 Commercial Way Unit 2, Spring Hill, Florida 34606 Ratings: Phone: (352) 688-4020 | |
Pinnacle Home Care Of Spring Hill Inc Location: 5286 Applegate Dr, Spring Hill, Florida 34606 Ratings: Phone: (352) 666-2771 | |
Able Care Connect Home Health Location: 3140 Forest Rd, Spring Hill, Florida 34606 Ratings: NA Phone: (952) 361-8000 | |
Horizon Homecare Llc Location: 2977 Landover Blvd, Spring Hill, Florida 34608 Ratings: Phone: (352) 684-3550 | |
Fusion Healthcare Location: 10508 Spring Hill Dr, Spring Hill, Florida 34608 Ratings: Phone: (352) 684-1388 |